News
We recently published a list of Was Jim Cramer Right About These 9 Stocks? In this article, we are going to take a look at ...
TD Cowen has lowered Eli Lilly’s price target from $1,050 to $960, but maintained a Buy rating, citing solid long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results